相关实验视频

Updated: Jun 15, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

标有Gd(III) 的自我组装作为潜在的pH响应的MRI对比剂

Carlo Martin M Ocampo¹, Aaron Joseph L Villaraza¹

¹Institute of Chemistry, University of the Philippines Diliman, Philippines. alvillaraza@up.edu.ph.

Dalton transactions (Cambridge, England : 2003)

|August 27, 2024

概括

一种新的类对比剂改变其结构与pH值,改变其MRI信号. 这种pH响应性行为对于开发先进的磁共振成像剂来监测组织变化是有用的.

科学领域:

生物结合化学生物结合化学
材料科学材料科学材料科学
生物医学成像技术生物医学成像技术

背景情况:

大分子对比剂对于磁共振成像 (MRI) 是至关重要的.
开发能够信号生理变化的响应剂是一个活跃的研究领域.
加多 (Gd(III)) - 酸盐是常见的MRI对比剂,但它们的稳定性和准具有挑战性.

研究的目的:

为了研究一种标有Gd(III) 酸盐的海洋衍生的pH依赖性自我组装.
评估自我组装对对比剂的放松性 (r1) 的影响.
探索这种pH响应剂在监测组织生理学方面的潜力.

主要方法:

一种与Gd(III) 酸盐结合的海洋衍生的合成和表征.
溶液中的自我组合的pH依赖性研究.
在分散状态和自组装状态中测量T1放松性 (r1).

主要成果:

酸-Gd(III) - 酸结合体表现出pH依赖的自我组装.
在分散型和自组装型之间观察到T1-放松性 (r1) 的显著变化.
观察到的pH响应性行为表明了动态成像的潜力.

结论:

海洋衍生的-Gd(III) - 酸是一种pH响应的宏分子剂.
它的自我组装和相关的放松性变化提供了一种感知生理pH的机制.
这种药物有望用于开发用于生理监测的新型MRI对比剂.

更多相关视频

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

Labeling DNA Probes

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...